Orphenadrine Citrate

Product NDC: 0185-0022
11-digit product format: 001850022
Labeler code: 0185
Product ID: 0185-0022_de0e8cdb-788a-4ebe-969d-14d44a14ddc2
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Orphenadrine Citrate
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Sandoz Inc
Application: ANDA040327
Marketing category: ANDA
Marketing start: 2000-02-15
Marketing end: 2027-03-20
Substance: ORPHENADRINE CITRATE
Active strength: 100 mg/1
Pharmacologic classes: Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
NDC exclude flag: No
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0185-0022	0185-0022-10	D	Discontinued by firm		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040327-001	ORPHENADRINE CITRATE	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A040327-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB		2000-02-15	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040327-001	ORPHENADRINE CITRATE	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RS	2000-02-15	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A040327-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040327-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040327-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040327-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040327-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040327-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040327-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040327-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040327-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040327-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040327-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040327-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040327-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040327-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040327-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040327-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040327-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040327-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040327-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040327-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040327-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040327-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040327-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040327-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040327-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040327-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040327-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A040327-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A040327-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A040327-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040327-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040327-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040327-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040327-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040327-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040327-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040327-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A040327-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040327-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040327-001	AB	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Orphenadrine Citrate

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ORPHENADRINE CITRATE	100 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
X0A40N8I4S	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
994521	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
239018ff-cec6-46de-ae9d-26c9ec034a32	Available on FDA.report

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0185-0022-01	Orphenadrine Citrate	100 in 1 BOTTLE	TABLET, EXTENDED RELEASE	100		21
0185-0022-10	Orphenadrine Citrate	1000 in 1 BOTTLE	TABLET, EXTENDED RELEASE	1000		21

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0185-0022-01	EA - Each	0185-0022	e462192d-edd3-48fb-b7ed-82c2144d9c96	1	2012-07-24
0185-0022-10	EA - Each	0185-0022	da3d5e14-2242-440c-8c5d-570f4e99a2fd	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ORPHENADRINE CITRATE	ACTIVE INGREDIENT	X0A40N8I4S	ORPHENADRINE CITRATE TABLET [EON LABS, INC.]	14
ORPHENADRINE	ACTIVE MOIETY	AL805O9OG9	ORPHENADRINE CITRATE TABLET [EON LABS, INC.]	14
CALCIUM STEARATE	INACTIVE INGREDIENT	776XM7047L	ORPHENADRINE CITRATE TABLET [EON LABS, INC.]	14
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	ORPHENADRINE CITRATE TABLET [EON LABS, INC.]	14
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ORPHENADRINE CITRATE TABLET [EON LABS, INC.]	14
ORPHENADRINE CITRATE	ACTIVE INGREDIENT	X0A40N8I4S	ORPHENADRINE CITRATE TABLET [CARILION MATERIALS MANAGEMENT]	2
ORPHENADRINE	ACTIVE MOIETY	AL805O9OG9	ORPHENADRINE CITRATE TABLET [CARILION MATERIALS MANAGEMENT]	2
CALCIUM STEARATE	INACTIVE INGREDIENT	776XM7047L	ORPHENADRINE CITRATE TABLET [CARILION MATERIALS MANAGEMENT]	2
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	ORPHENADRINE CITRATE TABLET [CARILION MATERIALS MANAGEMENT]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ORPHENADRINE CITRATE TABLET [CARILION MATERIALS MANAGEMENT]	2
ORPHENADRINE CITRATE	ACTIVE INGREDIENT	X0A40N8I4S	ORPHENADRINE CITRATE TABLET [MEDSOURCE PHARMACEUTICALS]	1
ORPHENADRINE CITRATE	ACTIVE INGREDIENT	X0A40N8I4S	ORPHENADRINE CITRATE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
ORPHENADRINE	ACTIVE MOIETY	AL805O9OG9	ORPHENADRINE CITRATE TABLET [MEDSOURCE PHARMACEUTICALS]	1
ORPHENADRINE	ACTIVE MOIETY	AL805O9OG9	ORPHENADRINE CITRATE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
CALCIUM STEARATE	INACTIVE INGREDIENT	776XM7047L	ORPHENADRINE CITRATE TABLET [MEDSOURCE PHARMACEUTICALS]	1
CALCIUM STEARATE	INACTIVE INGREDIENT	776XM7047L	ORPHENADRINE CITRATE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	ORPHENADRINE CITRATE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	ORPHENADRINE CITRATE TABLET [MEDSOURCE PHARMACEUTICALS]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ORPHENADRINE CITRATE TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ORPHENADRINE CITRATE TABLET [MEDSOURCE PHARMACEUTICALS]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0185-0022	ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [SANDOZ INC]	21	Current NDC, Legacy NDC, 2 package rows	20240322_239018ff-cec6-46de-ae9d-26c9ec034a32.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Orphenadrine Citrate	ORPHENADRINE CITRATE	RedPharm Drug	1cff761d-e594-a9e6-e063-6394a90a1fd5	2024-07-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040327 application number: ANDA040327
Orphenadrine Citrate	ORPHENADRINE CITRATE	Sandoz Inc	239018ff-cec6-46de-ae9d-26c9ec034a32	2024-03-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040327 application number: ANDA040327 ndc (product): 0185-0022
Orphenadrine Citrate	ORPHENADRINE CITRATE	Proficient Rx LP	37e6a157-5d0d-4887-9a26-ed5521fb08e6	2019-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040327 application number: ANDA040327

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X0A40N8I4S	ORPHENADRINE CITRATE	4682-36-4	ORPHENADRINE CITRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
994521	orphenadrine citrate 100 MG 12HR Extended Release Oral Tablet	PSN	239018ff-cec6-46de-ae9d-26c9ec034a32	21
994521	12 HR orphenadrine citrate 100 MG Extended Release Oral Tablet	SCD	239018ff-cec6-46de-ae9d-26c9ec034a32	21
994521	orphenadrine citrate 100 MG 12 HR Extended Release Oral Tablet	SY	239018ff-cec6-46de-ae9d-26c9ec034a32	21
994841	orphenadrine citrate 100 MG Oral Tablet	PSN	9c986cc2-3b57-43c4-b6c8-55ea6383ec9d	4
994841	orphenadrine citrate 100 MG Oral Tablet	SCD	9c986cc2-3b57-43c4-b6c8-55ea6383ec9d	4
994521	orphenadrine citrate 100 MG 12HR Extended Release Oral Tablet	PSN	37e6a157-5d0d-4887-9a26-ed5521fb08e6	2
994521	12 HR orphenadrine citrate 100 MG Extended Release Oral Tablet	SCD	37e6a157-5d0d-4887-9a26-ed5521fb08e6	2
994521	orphenadrine citrate 100 MG 12 HR Extended Release Oral Tablet	SY	37e6a157-5d0d-4887-9a26-ed5521fb08e6	2
994521	orphenadrine citrate 100 MG 12HR Extended Release Oral Tablet	PSN	1cff761d-e594-a9e6-e063-6394a90a1fd5	1
994521	orphenadrine citrate 100 MG 12HR Extended Release Oral Tablet	PSN	1d38a57b-946f-0776-e054-00144ff8d46c	1
994521	12 HR orphenadrine citrate 100 MG Extended Release Oral Tablet	SCD	1cff761d-e594-a9e6-e063-6394a90a1fd5	1
994521	12 HR orphenadrine citrate 100 MG Extended Release Oral Tablet	SCD	1d38a57b-946f-0776-e054-00144ff8d46c	1
994521	orphenadrine citrate 100 MG 12 HR Extended Release Oral Tablet	SY	1cff761d-e594-a9e6-e063-6394a90a1fd5	1
994521	orphenadrine citrate 100 MG 12 HR Extended Release Oral Tablet	SY	1d38a57b-946f-0776-e054-00144ff8d46c	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0185-0022-01	00185002201	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0185-0022-01)	2000-02-15	2027-03-20	No	No	Current
0185-0022-10	00185002210	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0185-0022-10)	2000-02-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Orphenadrine Citrate Extended-Release Tablets, USP	RedPharm Drug	2024-07-11	HUMAN PRESCRIPTION DRUG LABEL	1
Orphenadrine Citrate Extended-Release Tablets, USP	Sandoz Inc	2024-03-22	HUMAN PRESCRIPTION DRUG LABEL	21
Orphenadrine Citrate Extended-Release Tablets, USP	Bryant Ranch Prepack	2022-09-28	HUMAN PRESCRIPTION DRUG LABEL	8
Orphenadrine Citrate Extended-Release Tablets	Proficient Rx LP	2019-11-01	HUMAN PRESCRIPTION DRUG LABEL	2
Orphenadrine Citrate Extended-Release Tablets	Preferred Pharmaceuticals, Inc.	2017-12-07	HUMAN PRESCRIPTION DRUG LABEL	3
Orphenadrine Citrate Extended-Release Tablets, USP	Carilion Materials Management	2017-07-06	HUMAN PRESCRIPTION DRUG LABEL	4
Orphenadrine Citrate Extended-Release Tablets	Medsource Pharmaceuticals	2015-08-13	HUMAN PRESCRIPTION DRUG LABEL	1